(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -138.84%-5.54M | -34.61%5.42M | 637.67%7.02M | 3,031.38%30.55M | 1,409.58%9.3M | 4,471.47%14.26M | 628.03%8.29M | -241.04%-1.31M | 83.66%-1.04M | 89.08%-710K |
Net income from continuing operations | -89.69%-791K | 355.26%947K | -28.39%-900K | -122.12%-528K | 478.35%961K | -104.41%-417K | -125.41%-371K | -150.61%-701K | 381.25%2.39M | -205.39%-254K |
Operating gains losses | 53.55%-144K | 90.35%-83K | -18.14%853K | 104.85%51K | --253K | ---310K | ---860K | 11,677.78%1.04M | -169.72%-1.05M | ---- |
Depreciation and amortization | 24.65%1.77M | -31.13%1.68M | -52.09%1.72M | 30.92%9.19M | 3.91%1.75M | -23.04%1.42M | 25.67%2.44M | 130.80%3.58M | 13.05%7.02M | 54.11%1.69M |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.47M | ---- |
Remuneration paid in stock | 53.66%252K | 199.47%189K | 8.52%535K | 43.86%597K | -13.91%130K | 198.18%164K | -1,050.00%-190K | 160.85%493K | -39.86%415K | -26.34%151K |
Deferred tax | 14.88%-309K | 399.31%724K | -3.70%-224K | -100.49%-4K | 430.77%430K | -598.08%-363K | -69.28%145K | -140.83%-216K | 60.90%819K | -201.56%-130K |
Other non cashItems | -14.71%1.69M | 219.39%1.68M | -1.10%1.35M | 22.06%5.79M | 313.29%1.84M | 4.04%1.99M | -60.24%526K | 27.16%1.37M | 25.09%4.74M | -47.39%444K |
Change In working capital | -156.52%-7.25M | -85.02%1.18M | 179.24%4.71M | 236.04%19.65M | 250.81%4.87M | 613.33%12.83M | 236.71%7.9M | -102.18%-5.94M | 14.20%-14.44M | 60.84%-3.23M |
-Change in receivables | 99.28%-20K | -57.35%3.04M | 31.39%-3.21M | 126.36%1.77M | 405.31%2.09M | -1,071.19%-2.76M | 952.81%7.12M | 22.89%-4.68M | -642.53%-6.72M | -91.60%414K |
-Change in inventory | -292.51%-7.19M | -109.05%-1.98M | 30.17%5.22M | 203.11%37.21M | 357.20%7.6M | 129.81%3.74M | 317.49%21.87M | 138.02%4.01M | -170.12%-36.09M | 50.59%-2.95M |
-Change in prepaid assets | -441.30%-157K | 91.67%23K | 866.67%116K | 220.25%196K | -80.37%126K | 107.57%46K | 106.56%12K | 185.71%12K | -87.36%-163K | 635.00%642K |
-Change in payables and accrued expense | -58.97%4.09M | 112.15%2.4M | 202.20%2.33M | -181.60%-13.61M | 81.60%-1.53M | 4.93%9.97M | -496.45%-19.78M | -121.67%-2.28M | 605.92%16.68M | -85.05%-8.32M |
-Change in other working capital | -316.46%-3.97M | -73.08%-2.3M | 108.50%256K | -149.96%-5.92M | -148.85%-3.41M | 33.55%1.84M | -529.03%-1.33M | -194.72%-3.01M | 269.67%11.85M | 371.10%6.99M |
Interest paid (cash flow from operating activities) | -6.50%-1.44M | 4.51%-1.44M | -15.25%-1.41M | -44.92%-5.5M | -54.09%-1.41M | -57.33%-1.35M | -34.61%-1.51M | -36.53%-1.23M | -16.01%-3.8M | 3.37%-917K |
Interest received (cash flow from operating activities) | 64.06%525K | 28.67%543K | 32.32%393K | 239.87%1.53M | 255.47%487K | 158.06%320K | 191.03%422K | 590.70%297K | -18.51%449K | 29.25%137K |
Tax refund paid | 2,400.00%161K | --0 | ---- | -327.45%-218K | 70.59%-5K | ---7K | -505.88%-206K | ---- | -96.15%-51K | -1,600.00%-17K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -138.84%-5.54M | -34.61%5.42M | 637.67%7.02M | 3,031.38%30.55M | 1,409.58%9.3M | 4,471.47%14.26M | 628.03%8.29M | -241.04%-1.31M | 83.66%-1.04M | 89.08%-710K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 95.89%-188K | 95.25%-221K | 95.77%-351K | 20.54%-19.55M | 72.44%-2.02M | 9.55%-4.58M | 35.71%-4.66M | -66.57%-8.3M | -79.39%-24.61M | -147.00%-7.32M |
Net PPE purchase and sale | 95.89%-188K | 95.25%-221K | 95.77%-351K | 20.54%-19.55M | 72.44%-2.02M | 9.55%-4.58M | 35.71%-4.66M | -66.57%-8.3M | -79.39%-24.61M | -147.00%-7.32M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 95.89%-188K | 95.25%-221K | 95.77%-351K | 20.54%-19.55M | 72.44%-2.02M | 9.55%-4.58M | 35.71%-4.66M | -66.57%-8.3M | -79.39%-24.61M | -147.00%-7.32M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 131.86%2.33M | 61.60%-417K | -154.53%-4.16M | -114.57%-3.67M | -132.68%-2.9M | -214.63%-7.31M | -115.23%-1.09M | 176.13%7.64M | 16.50%25.16M | -23.32%8.88M |
Net issuance payments of debt | 131.86%2.33M | 59.08%-417K | -152.12%-4.16M | -112.71%-3.25M | -131.51%-2.9M | -213.58%-7.31M | -114.29%-1.02M | 188.86%7.99M | 16.39%25.55M | -19.64%9.21M |
Net other financing activities | ---- | ---- | ---- | -7.44%-419K | --0 | ---- | ---67K | ---352K | -9.55%-390K | -378.15%-331K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 131.86%2.33M | 61.60%-417K | -154.53%-4.16M | -114.57%-3.67M | -132.68%-2.9M | -214.63%-7.31M | -115.23%-1.09M | 176.13%7.64M | 16.50%25.16M | -23.32%8.88M |
Net cash flow | ||||||||||
Beginning cash position | 323.74%18.38M | 659.72%13.6M | 194.89%11.09M | -11.51%3.76M | 130.72%6.71M | 239.17%4.34M | -39.49%1.79M | -11.51%3.76M | 54.60%4.25M | 36.56%2.91M |
Current changes in cash | -243.06%-3.4M | 87.72%4.78M | 227.25%2.51M | 1,598.98%7.33M | 414.34%4.38M | 45.68%2.38M | 251.76%2.55M | -52.55%-1.97M | -132.58%-489K | -59.84%851K |
End cash Position | 123.16%14.98M | 323.74%18.38M | 659.72%13.6M | 194.89%11.09M | 194.89%11.09M | 130.72%6.71M | 239.17%4.34M | -39.49%1.79M | -11.51%3.76M | -11.51%3.76M |
Free cash from | -159.13%-5.73M | 43.09%5.2M | 169.45%6.67M | 139.34%10.63M | 186.04%6.91M | 299.40%9.69M | 141.24%3.63M | -81.01%-9.61M | -34.41%-27.01M | 15.14%-8.03M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data